Induction and Maintenance of Remission With Pentasa as Ulcerative Colitis Treatment

NCT02261636 · clinicaltrials.gov ↗

COMPLETED

Status

150

Enrollment

INDUSTRY

Sponsor class

Conditions

Ulcerative Colitis

Interventions

DRUG: mesalazine

Sponsor

Ferring Pharmaceuticals